Skip to Content
MDPIMDPI
Vaccines
Submit to Vaccines

Vaccines, Volume 12, Issue 3

2024 March - 124 articles

Cover Story: Nucleic acid vaccines (i.e., viral vectors, DNA vaccines and mRNA vaccines) provide multiple advantages over other vaccine platforms like subunit proteins or whole-pathogen vaccines. As demonstrated during the SARS-CoV-2 pandemics, their versatility and unique protocols allowed for fast adaptation to novel immunogens. These advantages can benefit the HIV vaccine field that is in dire need of delivery platforms that can be rapidly adapted to a highly mutating virus, while being highly immunogenic. Hence, combining the most relevant HIV immunogens as soluble proteins or those displayed on multivalent platforms with DNA and mRNA systems can pave the way towards the development of HIV vaccines. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles

There are no articles in this issue yet.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X
Imprint
Download Flyer